Seminars in Hematology
Volume 37, Issue 3 , Pages 219-221 , July 2000

Idiopathic immune thrombocytopenic purpura: An update

References 

  1. Bussel JB, Kimberly RP, Inman RD, et al.  Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 1983;62:480–486
  2. Bussel JB, Pham LC, Aledort L, et al.  Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood. 1988;72:121–127
  3. Dixon RH, Rosse WF. Platelet antibody in immune thrombocytopenia. Br J Haematol. 1975;31:129–134
  4. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982;306:1254–1258
  5. Harrington WJ, Minnich V, Hollingsworth JW, et al.  Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951;38:1–10
  6. Kelton JG, Murphy WG, Lucarelli A, et al.  A prospective comparison of four techniques for measuring platelet-associated IgG. Br J Haematol. 1989;71:97–105
  7. Kiefel VS, Santoso S, Weisheit M, et al.  Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet reactive antibodies. Blood. 1987;70:1722–1726
  8. McMillan R, Longmire RL, Yelenosky R, et al.  Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombo cytopenic purpura. N Engl J Med. 1972;286:681–684
  9. McMillan R, Tani P, Berchtold P, et al.  Platelet associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987;70:1040–1045
  10. Mueller-Eckhardt C, Kayser W, Mersch-Baumert K, et al.  The clinical significance of platelet-associated IgG: A study on 298 patients with various disorders. Br J Haematol. 1980;46:123–131
  11. Rodeghiero F, Schiavotto C, Castaman G, et al.  A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematologia. 1992;77:248–252
  12. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells?. Lancet. 1983;2:193–195
  13. Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: Physiologic, serologic and isotopic studies. Ann NY Acad Sci. 1965;124:499–542
  14. Shulman NR, Weinrach RS, Libre EP, et al.  The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians. 1965;78:374–390
  15. Sinha RK, Kelton JG. Current controversies concerning the measurement of platelet associated IgG. Transfus Med Rev. 1990;4:121–135
  16. Smith JW, Hayward CP, Warkentin T, et al.  Investigation of human platelet alloantigens and glycoproteins using nonradioactive immunoprecipitation. J Immunol Methods. 1993;158:77–85
  17. Stefanini M, Dameshek W, Charterjea J, et al.  Studies on platelets. DC Observations on the properties and mechanism of action of a potent platelet agglutinin detected in the serum of a patient with idiopathic thrombocytopenic purpura (with a note on the pathogenesis of the disease). Blood. 1953;8:26–64
  18. Van Leeuwen EF, Van der Ven J, Engelfriet CP, et al.  Specificity of autoantibodies in autoimmune thrombocytopenia. Blood. 1982;59:23–26
  19. Warner M, Kelton JG. Laboratory investigation of immune thrombocytopenia. J Clin Pathol. 1997;50:5–12
  20. Woods VS, Oh EH, Mason D, et al.  Autoantibodies against platelet glycoprotein Ilb/IIIa complex in patients with chronic ITP. Blood. 1984;63:368–375

PII: S0037-1963(00)90099-4

Seminars in Hematology
Volume 37, Issue 3 , Pages 219-221 , July 2000

Article Tools